BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

769 related articles for article (PubMed ID: 26724488)

  • 1. Over 1-year efficacy and safety of left atrial appendage occlusion versus novel oral anticoagulants for stroke prevention in atrial fibrillation: A systematic review and meta-analysis of randomized controlled trials and observational studies.
    Li X; Wen SN; Li SN; Bai R; Liu N; Feng L; Ruan YF; Du X; Dong JZ; Ma CS
    Heart Rhythm; 2016 Jun; 13(6):1203-14. PubMed ID: 26724488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left Atrial Appendage Occlusion Device and Novel Oral Anticoagulants Versus Warfarin for Stroke Prevention in Nonvalvular Atrial Fibrillation: Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Briceno DF; Villablanca P; Cyrille N; Massera D; Bader E; Manheimer E; Aagaard P; Ferrick K; Gross J; Kim SG; Krumerman A; Palma E; Guttenplan N; Romero J; Fisher J; Garcia M; Natale A; Di Biase L
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1057-64. PubMed ID: 26226997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of left atrial appendage closure versus medical treatment in atrial fibrillation: a network meta-analysis from randomised trials.
    Sahay S; Nombela-Franco L; Rodes-Cabau J; Jimenez-Quevedo P; Salinas P; Biagioni C; Nuñez-Gil I; Gonzalo N; de Agustín JA; Del Trigo M; Perez de Isla L; Fernández-Ortiz A; Escaned J; Macaya C
    Heart; 2017 Jan; 103(2):139-147. PubMed ID: 27587437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Left atrial appendage occlusion vs novel oral anticoagulation for stroke prevention in atrial fibrillation: rationale and design of the multicenter randomized occlusion-AF trial.
    Korsholm K; Damgaard D; Valentin JB; Packer EJS; Odenstedt J; Sinisalo J; Putaala J; Næss H; Al-Jazi MA; Karlsson JE; Pontoppidan J; Modrau B; Hjort J; Matzen KL; Johnsen SP; Nielsen-Kudsk JE
    Am Heart J; 2022 Jan; 243():28-38. PubMed ID: 34537184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left atrial appendage closure versus non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation and high bleeding risk.
    Godino C; Melillo F; Bellini B; Mazzucca M; Pivato CA; Rubino F; Figini F; Mazzone P; Della Bella P; Margonato A; Colombo A; Montorfano M
    EuroIntervention; 2020 Apr; 15(17):1548-1554. PubMed ID: 31845892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An updated systematic review and meta-analysis of early outcomes after left atrial appendage occlusion.
    Yerasi C; Lazkani M; Kolluru P; Miryala V; Kim J; Moole H; Sawant AC; Morris M; Pershad A
    J Interv Cardiol; 2018 Apr; 31(2):197-206. PubMed ID: 29495123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left Atrial Appendage Occlusion as Adjunctive Therapy to Anticoagulation for Stroke Recurrence.
    Freixa X; Cruz-González I; Regueiro A; Nombela-Franco L; Estévez-Loureiro R; Ruiz-Salmerón R; Bethencourt A; Gutiérrez-García H; Fernández-Díaz JA; Moreno-Samos JC; Jiménez-Quevedo P; Martin-Yuste V; Arnold R; Millan X; Asmarats L; Ronquillo M; Agudelo-Montañez VH; López-Mínguez JR; Goicolea J; Pérez de Prado A; Arzamendi D
    J Invasive Cardiol; 2019 Aug; 31(8):212-216. PubMed ID: 31088992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials.
    Bajaj NS; Kalra R; Patel N; Hashim T; Godara H; Ather S; Arora G; Pasala T; Whitfield TT; McGiffin DC; Ahmed MI; Lloyd SG; Limdi NA; Arora P
    PLoS One; 2016; 11(10):e0163608. PubMed ID: 27706224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head-to-head comparison between left atrial appendage occlusion and non-vitamin K oral anticoagulants in non-valvular atrial fibrillation patients: A systematic review and meta-analysis study.
    Waranugraha Y; Lin LY; Tsai CT
    Trends Cardiovasc Med; 2024 May; 34(4):225-233. PubMed ID: 36775218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left atrial appendage occlusion with the Amplatzer Cardiac Plug could improve survival and prevent thrombo-embolic and major bleeding events in atrial fibrillation patients with increased bleeding risk.
    Budts W; Laenens D; Van Calenbergh F; Vermeersch P; De Potter T; Aminian A; Benit E; Stammen F; Kefer J
    Acta Cardiol; 2016 Apr; 71(2):135-43. PubMed ID: 27090034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous Left Atrial Appendage Closure with WATCHMAN™ device: peri-procedural and mid-term outcomes from the TRAPS Registry.
    Mazzone P; D'Angelo G; Regazzoli D; Molon G; Senatore G; Saccà S; Canali G; Amellone C; Turri R; Bella PD
    J Interv Card Electrophysiol; 2018 Jun; 52(1):47-52. PubMed ID: 29525913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left atrial appendage occlusion for prevention of stroke in nonvalvular atrial fibrillation: a meta-analysis.
    Bode WD; Patel N; Gehi AK
    J Interv Card Electrophysiol; 2015 Jun; 43(1):79-89. PubMed ID: 25711953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
    Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous left atrial appendage occlusion in atrial fibrillation patients with a contraindication to oral anticoagulation: a focused review.
    Nishimura M; Sab S; Reeves RR; Hsu JC
    Europace; 2018 Sep; 20(9):1412-1419. PubMed ID: 29228158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Left Atrial Appendage Closure for Stroke Reduction in Atrial Fibrillation: Analysis of Pooled, 5-Year, Long-Term Data.
    Reddy VY; Akehurst RL; Gavaghan MB; Amorosi SL; Holmes DR
    J Am Heart Assoc; 2019 Jul; 8(13):e011577. PubMed ID: 31230500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of non-warfarin oral anticoagulants instead of warfarin during left atrial appendage closure with the Watchman device.
    Enomoto Y; Gadiyaram VK; Gianni C; Horton RP; Trivedi C; Mohanty S; Di Biase L; Al-Ahmad A; Burkhardt JD; Narula A; Janczyk G; Price MJ; Afzal MR; Atoui M; Earnest M; Swarup V; Doshi SK; van der Zee S; Fisher R; Lakkireddy DR; Gibson DN; Natale A; Reddy VY
    Heart Rhythm; 2017 Jan; 14(1):19-24. PubMed ID: 27771552
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical follow-up of left atrial appendage occlusion in patients with atrial fibrillation ineligible of oral anticoagulation treatment-a systematic review and meta-analysis.
    Labori F; Bonander C; Persson J; Svensson M
    J Interv Card Electrophysiol; 2021 Aug; 61(2):215-225. PubMed ID: 33580847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial appendage occlusion in patients older than 85 years. Safety and efficacy in the EWOLUTION registry.
    Cruz-González I; Ince H; Kische S; Schmitz T; Schmidt B; Gori T; Foley D; de Potter T; Tschishow W; Vireca E; Stein K; Boersma LV
    Rev Esp Cardiol (Engl Ed); 2020 Jan; 73(1):21-27. PubMed ID: 30956034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left Atrial Appendage Occlusion: A Narrative Review.
    Alsagheir A; Koziarz A; Belley-Côté EP; Whitlock RP
    J Cardiothorac Vasc Anesth; 2019 Jun; 33(6):1753-1765. PubMed ID: 30857852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical left atrial appendage occlusion during cardiac surgery for patients with atrial fibrillation: a meta-analysis.
    Tsai YC; Phan K; Munkholm-Larsen S; Tian DH; La Meir M; Yan TD
    Eur J Cardiothorac Surg; 2015 May; 47(5):847-54. PubMed ID: 25064051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.